Main Menu

Ayala Pharmaceuticals, Inc.


Rigrodsky Law, P.A. is investigating Ayala Pharmaceuticals, Inc. (“Ayala”) regarding possible breaches of fiduciary duties and other violations of law related to Ayala’s agreement to merge with Advaxis, Inc. (“Advaxis”). Under the terms of the agreement, Ayala shareholders will receive 0.1874 shares of Advaxis common stock for each share of Ayala common stock.

Join This Action

Alternatively, you may upload your transactions using the upload button below or email them to

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 11/23/2022

* Indicates a required field.

Back to Page